Rhenman & Partners Asset Management Ab Immunocore Holdings PLC Transaction History
Rhenman & Partners Asset Management Ab
- $840 Million
- Q1 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 28,278 shares of IMCR stock, worth $907,723. This represents 0.1% of its overall portfolio holdings.
Number of Shares
28,278
Previous 58,278
51.48%
Holding current value
$907,723
Previous $1.72 Million
51.19%
% of portfolio
0.1%
Previous 0.18%
Shares
12 transactions
Others Institutions Holding IMCR
# of Institutions
133Shares Held
44.6MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$226 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$197 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$156 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$86 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$74.6 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.41B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...